Rupa Mehta, Nitin M Nagarkar, Atul Jindal, Karthik Nagaraja Rao, S B Nidhin, Ripu Daman Arora, Anil Sharma, Archana Wankhede, Satish Satpute, Sharmistha Chakravarty, N K Agrawal, Pranita, Pankaj Kannauje, Ajoy Behera, Pugazhenthan Thangaraju
The study aimed to determine clinical presentation, contributing factors, medical and surgical management, and outcome of patients with coronavirus disease 2019 (COVID-19)-associated mucormycosis (CAM). A cross-sectional, single-center study was conducted on patients receiving multidisciplinary treatment for mucormycosis following the second wave of COVID-19 pandemic from April to June 2021 in India. Clinicoepidemiological factors were analyzed, 30-day overall survival and disease-specific survival were determined, and t -test was used to determine the statistical significance...
October 6, 2021: Indian Journal of Surgery